Your browser doesn't support javascript.
loading
Expensive Drugs for Rare Diseases in Canada: What Value and at What Cost?
Sirrs, Sandra; Anderson, Helen; Jiwani, Bashir; Lynd, Larry D; Lun, Eric; Nakagawa, Bob; Regier, Dean; Rizzardo, Shirin; McFarlane, Anne.
Afiliação
  • Sirrs S; Clinical Professor, Division of Endocrinology, Department of Medicine, University of British Columbia, Vancouver, BC.
  • Anderson H; Director, Systemic Therapy, BC Cancer, Victoria, BC.
  • Jiwani B; Lead Ethicist and Executive Director, Ethics and Diversity Services, Fraser Health Authority, Surrey, BC.
  • Lynd LD; Associate Dean, Research, Professor and Director, Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC.
  • Lun E; Executive Director, BC Transplant, Provincial Specialized Programs and Clinical Policy, Provincial Health Services Authority, Vancouver, BC.
  • Nakagawa B; Former Assistant Deputy Minister - Pharmaceutical Services Division, BC Ministry of Health, Coquitlam, BC.
  • Regier D; Clinical Scientist, Cancer Control Research, BC Cancer, Associate Professor, School of Population and Public Health, University of British Columbia, Vancouver, BC.
  • Rizzardo S; Senior Economic and Socioeconomic Analyst, Patented Medicine Prices Review Board, Vancouver, BC.
  • McFarlane A; Chair, British Columbia Expensive Drugs for Rare Diseases Advisory Committee, Provincial Health Services Authority, Victoria, BC.
Healthc Pap ; 21(1): 10-26, 2023 01.
Article em En | MEDLINE | ID: mdl-36692912
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Doenças Raras Tipo de estudo: Health_economic_evaluation Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Doenças Raras Tipo de estudo: Health_economic_evaluation Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article